BioVie Inc. (BIVI) – FDA
-
BioVie's (BIVI) NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients
-
BioVie Inc. (BIVI) Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BIVI Stock Lookup